These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18871882)

  • 1. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.
    EAGLE H; MUSSELMAN AD
    J Exp Med; 1948 Jul; 88(1):99-131. PubMed ID: 18871882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse inoculum effect in bactericidal activity and other variables affecting killing of group B streptococci by penicillin.
    Jokipii L; Brander P; Jokipii AM
    Antimicrob Agents Chemother; 1985 Jun; 27(6):948-52. PubMed ID: 3896137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding of penicillin in relation to its cytotoxic action. II. The reactivity with penicillin of resistant variants of streptococci, pneumococci, and staphylococci.
    EAGLE H
    J Exp Med; 1954 Jul; 100(1):103-15. PubMed ID: 13163342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.
    Overturf GD; Horowitz M; Wilkins J; Leedom J; Steinberg E
    J Antibiot (Tokyo); 1977 Jun; 30(6):513-8. PubMed ID: 328471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism, killing kinetics, and antimicrobial susceptibility of group A and B streptococci.
    Baker CN; Thornsberry C; Facklam RR
    Antimicrob Agents Chemother; 1981 May; 19(5):716-25. PubMed ID: 7027921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of bactericidal activity against group B streptococci with reduced penicillin susceptibility by uptake of gentamicin into cells resulting from combination with β-lactam antibiotics.
    Ebara Y; Morozumi M; Sato M; Moritoki N; Toyofuku M; Takata M; Murata M; Ubukata K; Iwata S
    J Infect Chemother; 2017 May; 23(5):312-318. PubMed ID: 28341517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE THERAPEUTIC ACTIVITY OF PENICILLINS F, G, K, AND X IN EXPERIMENTAL INFECTIONS WITH PNEUMOCOCCUS TYPE I AND STREPTOCOCCUS PYOGENES.
    Eagle H;
    J Exp Med; 1947 Jan; 85(2):175-86. PubMed ID: 19871606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of mastitis pathogens to antibiotics and chemotherapeutic agents].
    Kunter E
    Arch Exp Veterinarmed; 1975; 29(1):1-32. PubMed ID: 1106346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the size of the inoculum and the age of the infection on the curative dose of penicillin in experimental infections with streptococci, pneumococci, and Treponema pallidum.
    EAGLE H
    J Exp Med; 1949 Dec; 90(6):595-607. PubMed ID: 15394076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum on gram-positive cocci grown in the presence of penicillin.
    Lorian V; Atkinson B
    J Infect Dis; 1978 Dec; 138(6):865-71. PubMed ID: 105057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Penicillin tolerance in group A beta-hemolytic streptococci isolated from throat cultures of children with tonsillopharyngitis].
    Ciftçi E; Doğru U; Güriz H; Aysev AD; Ince E
    Mikrobiyol Bul; 2002 Apr; 36(2):147-52. PubMed ID: 12652866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experimental analysis of the curative action of penicillin in acute bacterial infections. I. The relationship of bacterial growth rates to the antimicrobial effect of penicillin.
    WOOD WB; SMITH MR
    J Exp Med; 1956 Apr; 103(4):487-98. PubMed ID: 13306857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group B streptococcal infective endocarditis.
    Backes RJ; Wilson WR; Geraci JE
    Arch Intern Med; 1985 Apr; 145(4):693-6. PubMed ID: 3885892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis.
    Brook I
    J Fam Pract; 1994 Feb; 38(2):175-9. PubMed ID: 8308510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.
    Desbiolles N; Piroth L; Lequeu C; Neuwirth C; Portier H; Chavanet P
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3328-33. PubMed ID: 11709304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amoxycillin: a new semi-synthetic penicillin.
    Sutherland R; Croydon EA; Rolinson GN
    Br Med J; 1972 Jul; 3(5817):13-6. PubMed ID: 4402672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin tolerance of human isolates of group C streptococci.
    Portnoy D; Prentis J; Richards GK
    Antimicrob Agents Chemother; 1981 Aug; 20(2):235-8. PubMed ID: 7283420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.